Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women

Ting Yuan David Cheng, Xiaoling Song, Shirley A.A. Beresford, Gloria Y.F. Ho, Karen Johnson, Mridul Datta, Rowan T. Chlebowski, Jean Wactawski-Wende, Lihong Qi, Marian L. Neuhouser

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Purpose: Vitamin D has been implicated in lowering lung cancer risk, but serological data on the association among never-smoking women are limited. We report results examining the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with lung cancer risk among female never smokers. We also examined whether the association was modified by vitamin D supplementation and serum vitamin A concentrations. Methods: In the Women’s Health Initiative, including the calcium/vitamin D (CaD) Trial, we selected 298 incident cases [191 non-small cell lung cancer (NSCLC) including 170 adenocarcinoma] and 298 matched controls of never smokers. Baseline serum 25(OH)D was assayed by a chemiluminescent method. Logistic regression was used to estimate odds ratios (ORs) for quartiles and predefined clinical cutoffs of serum 25(OH)D concentrations. Results: Comparing quartiles 4 versus 1 of serum 25(OH)D concentrations, ORs were 1.06 [95% confidence interval (CI) 0.61–1.84] for all lung cancer, 0.94 (95% CI 0.52–1.69) for NSCLC, and 0.91 (95% CI 0.49–1.68) for adenocarcinoma. Comparing serum 25(OH)D ≥ 75 (high) versus <30 nmol/L (deficient), ORs were 0.76 (95% CI 0.31–1.84) for all lung cancer, 0.71 (95% CI 0.27–1.86) for NSCLC, and 0.81 (95% CI 0.31–2.14) for adenocarcinoma. There is suggestive evidence that CaD supplementation (1 g calcium + 400 IU D3/day) and a high level of circulating vitamin A may modify the associations of 25(OH)D with lung cancer overall and subtypes (p interaction <0.10). Conclusions: In this group of never-smoking postmenopausal women, the results did not support the hypothesis of an association between serum 25(OH)D and lung cancer risk.

Original languageEnglish (US)
Pages (from-to)1053-1063
Number of pages11
JournalCancer Causes and Control
Volume28
Issue number10
DOIs
StatePublished - Oct 1 2017

Fingerprint

Lung Neoplasms
Smoking
Confidence Intervals
Vitamin D
Serum
Non-Small Cell Lung Carcinoma
Adenocarcinoma
Odds Ratio
Calcium
Vitamin A
Women's Health
25-hydroxyvitamin D
Logistic Models

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Cheng, T. Y. D., Song, X., Beresford, S. A. A., Ho, G. Y. F., Johnson, K., Datta, M., ... Neuhouser, M. L. (2017). Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. Cancer Causes and Control, 28(10), 1053-1063. https://doi.org/10.1007/s10552-017-0956-1

Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. / Cheng, Ting Yuan David; Song, Xiaoling; Beresford, Shirley A.A.; Ho, Gloria Y.F.; Johnson, Karen; Datta, Mridul; Chlebowski, Rowan T.; Wactawski-Wende, Jean; Qi, Lihong; Neuhouser, Marian L.

In: Cancer Causes and Control, Vol. 28, No. 10, 01.10.2017, p. 1053-1063.

Research output: Contribution to journalArticle

Cheng, TYD, Song, X, Beresford, SAA, Ho, GYF, Johnson, K, Datta, M, Chlebowski, RT, Wactawski-Wende, J, Qi, L & Neuhouser, ML 2017, 'Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women', Cancer Causes and Control, vol. 28, no. 10, pp. 1053-1063. https://doi.org/10.1007/s10552-017-0956-1
Cheng, Ting Yuan David ; Song, Xiaoling ; Beresford, Shirley A.A. ; Ho, Gloria Y.F. ; Johnson, Karen ; Datta, Mridul ; Chlebowski, Rowan T. ; Wactawski-Wende, Jean ; Qi, Lihong ; Neuhouser, Marian L. / Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women. In: Cancer Causes and Control. 2017 ; Vol. 28, No. 10. pp. 1053-1063.
@article{bba1c44ba187418d95ffde57a9615209,
title = "Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women",
abstract = "Purpose: Vitamin D has been implicated in lowering lung cancer risk, but serological data on the association among never-smoking women are limited. We report results examining the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with lung cancer risk among female never smokers. We also examined whether the association was modified by vitamin D supplementation and serum vitamin A concentrations. Methods: In the Women’s Health Initiative, including the calcium/vitamin D (CaD) Trial, we selected 298 incident cases [191 non-small cell lung cancer (NSCLC) including 170 adenocarcinoma] and 298 matched controls of never smokers. Baseline serum 25(OH)D was assayed by a chemiluminescent method. Logistic regression was used to estimate odds ratios (ORs) for quartiles and predefined clinical cutoffs of serum 25(OH)D concentrations. Results: Comparing quartiles 4 versus 1 of serum 25(OH)D concentrations, ORs were 1.06 [95{\%} confidence interval (CI) 0.61–1.84] for all lung cancer, 0.94 (95{\%} CI 0.52–1.69) for NSCLC, and 0.91 (95{\%} CI 0.49–1.68) for adenocarcinoma. Comparing serum 25(OH)D ≥ 75 (high) versus <30 nmol/L (deficient), ORs were 0.76 (95{\%} CI 0.31–1.84) for all lung cancer, 0.71 (95{\%} CI 0.27–1.86) for NSCLC, and 0.81 (95{\%} CI 0.31–2.14) for adenocarcinoma. There is suggestive evidence that CaD supplementation (1 g calcium + 400 IU D3/day) and a high level of circulating vitamin A may modify the associations of 25(OH)D with lung cancer overall and subtypes (p interaction <0.10). Conclusions: In this group of never-smoking postmenopausal women, the results did not support the hypothesis of an association between serum 25(OH)D and lung cancer risk.",
author = "Cheng, {Ting Yuan David} and Xiaoling Song and Beresford, {Shirley A.A.} and Ho, {Gloria Y.F.} and Karen Johnson and Mridul Datta and Chlebowski, {Rowan T.} and Jean Wactawski-Wende and Lihong Qi and Neuhouser, {Marian L.}",
year = "2017",
month = "10",
day = "1",
doi = "10.1007/s10552-017-0956-1",
language = "English (US)",
volume = "28",
pages = "1053--1063",
journal = "Cancer Causes and Control",
issn = "0957-5243",
publisher = "Springer Netherlands",
number = "10",

}

TY - JOUR

T1 - Serum 25-hydroxyvitamin D concentrations and lung cancer risk in never-smoking postmenopausal women

AU - Cheng, Ting Yuan David

AU - Song, Xiaoling

AU - Beresford, Shirley A.A.

AU - Ho, Gloria Y.F.

AU - Johnson, Karen

AU - Datta, Mridul

AU - Chlebowski, Rowan T.

AU - Wactawski-Wende, Jean

AU - Qi, Lihong

AU - Neuhouser, Marian L.

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Purpose: Vitamin D has been implicated in lowering lung cancer risk, but serological data on the association among never-smoking women are limited. We report results examining the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with lung cancer risk among female never smokers. We also examined whether the association was modified by vitamin D supplementation and serum vitamin A concentrations. Methods: In the Women’s Health Initiative, including the calcium/vitamin D (CaD) Trial, we selected 298 incident cases [191 non-small cell lung cancer (NSCLC) including 170 adenocarcinoma] and 298 matched controls of never smokers. Baseline serum 25(OH)D was assayed by a chemiluminescent method. Logistic regression was used to estimate odds ratios (ORs) for quartiles and predefined clinical cutoffs of serum 25(OH)D concentrations. Results: Comparing quartiles 4 versus 1 of serum 25(OH)D concentrations, ORs were 1.06 [95% confidence interval (CI) 0.61–1.84] for all lung cancer, 0.94 (95% CI 0.52–1.69) for NSCLC, and 0.91 (95% CI 0.49–1.68) for adenocarcinoma. Comparing serum 25(OH)D ≥ 75 (high) versus <30 nmol/L (deficient), ORs were 0.76 (95% CI 0.31–1.84) for all lung cancer, 0.71 (95% CI 0.27–1.86) for NSCLC, and 0.81 (95% CI 0.31–2.14) for adenocarcinoma. There is suggestive evidence that CaD supplementation (1 g calcium + 400 IU D3/day) and a high level of circulating vitamin A may modify the associations of 25(OH)D with lung cancer overall and subtypes (p interaction <0.10). Conclusions: In this group of never-smoking postmenopausal women, the results did not support the hypothesis of an association between serum 25(OH)D and lung cancer risk.

AB - Purpose: Vitamin D has been implicated in lowering lung cancer risk, but serological data on the association among never-smoking women are limited. We report results examining the association of serum 25-hydroxyvitamin D [25(OH)D] concentrations with lung cancer risk among female never smokers. We also examined whether the association was modified by vitamin D supplementation and serum vitamin A concentrations. Methods: In the Women’s Health Initiative, including the calcium/vitamin D (CaD) Trial, we selected 298 incident cases [191 non-small cell lung cancer (NSCLC) including 170 adenocarcinoma] and 298 matched controls of never smokers. Baseline serum 25(OH)D was assayed by a chemiluminescent method. Logistic regression was used to estimate odds ratios (ORs) for quartiles and predefined clinical cutoffs of serum 25(OH)D concentrations. Results: Comparing quartiles 4 versus 1 of serum 25(OH)D concentrations, ORs were 1.06 [95% confidence interval (CI) 0.61–1.84] for all lung cancer, 0.94 (95% CI 0.52–1.69) for NSCLC, and 0.91 (95% CI 0.49–1.68) for adenocarcinoma. Comparing serum 25(OH)D ≥ 75 (high) versus <30 nmol/L (deficient), ORs were 0.76 (95% CI 0.31–1.84) for all lung cancer, 0.71 (95% CI 0.27–1.86) for NSCLC, and 0.81 (95% CI 0.31–2.14) for adenocarcinoma. There is suggestive evidence that CaD supplementation (1 g calcium + 400 IU D3/day) and a high level of circulating vitamin A may modify the associations of 25(OH)D with lung cancer overall and subtypes (p interaction <0.10). Conclusions: In this group of never-smoking postmenopausal women, the results did not support the hypothesis of an association between serum 25(OH)D and lung cancer risk.

UR - http://www.scopus.com/inward/record.url?scp=85029179110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85029179110&partnerID=8YFLogxK

U2 - 10.1007/s10552-017-0956-1

DO - 10.1007/s10552-017-0956-1

M3 - Article

C2 - 28900765

AN - SCOPUS:85029179110

VL - 28

SP - 1053

EP - 1063

JO - Cancer Causes and Control

JF - Cancer Causes and Control

SN - 0957-5243

IS - 10

ER -